Net Cash Provided by (Used in) Operating Activities |
-59.5K |
USD |
-407% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
7.65K |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
45M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
1.6M |
shares |
-91.1% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-62.8K |
USD |
+78.1% |
Q1 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
87.7K |
USD |
+21% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
203 |
USD |
-57.1% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
12.3M |
USD |
|
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
8.79M |
USD |
+2.91% |
Q4 2023 |
FY 2023 |
Operating Lease, Payments |
434 |
USD |
|
Q3 2022 |
Q3 2022 |
Additional Paid in Capital |
35.3M |
USD |
+5.54% |
Q3 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
0 |
USD |
-100% |
Q3 2022 |
Q3 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
164K |
USD |
|
Q3 2024 |
Q3 2024 |
Share-based Payment Arrangement, Expense |
361K |
USD |
|
Q4 2023 |
FY 2023 |
Interest Expense |
5.46K |
USD |
|
Q2 2023 |
Q2 2023 |